Diagnosing and treating sepsis.

When seconds matter.

About Us

PATH EX Therapy

PATH EX is developing an extracorporeal blood cleansing device designed to selectively remove  pathogens, including multi-drug resistant bacteria, and endotoxins from circulating blood. 

PATH EX Device

The PATH EX device significantly reduces pathogen and endotoxin levels, which has been validated in preclinical studies. The device represents a novel, promising strategy for immediate treatment in bacteremia and sepsis. 

PATH EX Pre-clinical Studies

Pre-clinical studies with the PATH EX device have demonstrated a reduction in the concentration of bacteria in the bloodstream by over 95 percent in just a single pass of contaminated blood. 

Contact Us

Drop us a line!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.




USA Today article about our CEO - Sinead MIller

Find out more

PATH EX awarded NSF SBIR Phase II grant

Find out more

PATH EX wins LA Startup Prize

Find out more

PATH EX wins 36|86 Student Edition

Find out more

PATH EX awarded NSF STTR Phase I grant

Find out more

Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.